{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:28:06Z","timestamp":1793327286099,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07226-3","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:12:16Z","timestamp":1760602336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fusobacterium nucleatum enhances oxaliplatin resistance in colon cancer by increasing PVT1 expression"],"prefix":"10.1186","volume":"23","author":[{"given":"Kangqi","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9601-8210","authenticated-orcid":false,"given":"Guiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"issue":"2","key":"7226_CR1","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"7226_CR2","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/j.gastro.2018.11.060","volume":"156","author":"CC Murphy","year":"2019","unstructured":"Murphy CC, Wallace K, Sandler RS, Baron JA. Racial disparities in incidence of young-onset colorectal cancer and patient survival. Gastroenterology. 2019;156(4):958\u201365.","journal-title":"Gastroenterology"},{"issue":"2","key":"7226_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/gutjnl-2019-318589","volume":"69","author":"M Zorzi","year":"2020","unstructured":"Zorzi M, Zappa M. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates. Gut. 2020;69(2):311\u201316.","journal-title":"Gut"},{"issue":"4","key":"7226_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391.","journal-title":"Gut"},{"key":"7226_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2017.11.040","volume":"415","author":"Z Fang","year":"2018","unstructured":"Fang Z, Gong C, Yu S, Zhou W, Hassan W, Li H, et al. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling. Cancer Lett. 2018;415:58\u201372.","journal-title":"Cancer Lett"},{"key":"7226_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejca.2021.01.051","volume":"148","author":"G Rosati","year":"2021","unstructured":"Rosati G, Lonardi S, Galli F, Di Bartolomeo M, Ronzoni M, Zampino MG, et al. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: a subgroup analysis from the Tosca trial. Eur J Cancer. 2021;148:190\u2013201.","journal-title":"Eur J Cancer"},{"issue":"3","key":"7226_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170(3):548\u201363.e16.","journal-title":"Cell"},{"issue":"1","key":"7226_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13046-018-0985-y","volume":"38","author":"S Zhang","year":"2019","unstructured":"Zhang S, Yang Y, Weng W, Guo B, Cai G, Ma Y, et al. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. J Exp Clin Cancer Res. 2019;38(1):14.","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"7226_CR9","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3390\/microorganisms11082004","volume":"11","author":"S Nawab","year":"2023","unstructured":"Nawab S, Bao Q, Ji LH, Luo Q, Fu X, Fan S, et al. The pathogenicity of fusobacterium nucleatum modulated by dietary fibers-A possible missing link between the dietary composition and the risk of colorectal cancer. Microorganisms. 2023;11(8):2004.","journal-title":"Microorganisms"},{"key":"7226_CR10","doi-asserted-by":"publisher","first-page":"710165","DOI":"10.3389\/fcell.2021.710165","volume":"9","author":"S Wang","year":"2021","unstructured":"Wang S, Liu Y, Li J, Zhao L, Yan W, Lin B, et al. Fusobacterium nucleatum acts as a pro-carcinogenic bacterium in colorectal cancer: from association to causality. Front Cell Dev Biol. 2021;9:710165.","journal-title":"Front. Cell Dev. Biol"},{"issue":"8007","key":"7226_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-024-07182-w","volume":"628","author":"M Zepeda-Rivera","year":"2024","unstructured":"Zepeda-Rivera M, Minot SS, Bouzek H, Wu H, Blanco-M\u00edguez A, Manghi P, et al. A distinct fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature. 2024;628(8007):424\u201332.","journal-title":"Nature"},{"issue":"1","key":"7226_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12943-024-01939-7","volume":"23","author":"Z Bian","year":"2024","unstructured":"Bian Z, Yang F, Xu P, Gao G, Yang C, Cao Y, et al. LINC01852 inhibits the tumorigenesis and chemoresistance in colorectal cancer by suppressing SRSF5-mediated alternative splicing of PKM. Mol Cancer. 2024;23(1):23.","journal-title":"Mol Cancer"},{"key":"7226_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.omtn.2020.03.006","volume":"20","author":"H Wu","year":"2020","unstructured":"Wu H, Wei M, Jiang X, Tan J, Xu W, Fan X, et al. lncRNA PVT1 promotes tumorigenesis of colorectal cancer by stabilizing miR-16-5p and interacting with the VEGFA\/VEGFR1\/AKT Axis. Mol Ther Nucleic Acids. 2020;20:438\u201350.","journal-title":"Mol Ther Nucleic Acids"},{"key":"7226_CR14","doi-asserted-by":"publisher","first-page":"103362","DOI":"10.1016\/j.redox.2024.103362","volume":"77","author":"Z Xin","year":"2024","unstructured":"Xin Z, Hu C, Zhang C, Liu M, Li J, Sun X, et al. LncRNA-HMG incites colorectal cancer cells to chemoresistance via repressing p53-mediated ferroptosis. Redox Biol. 2024;77:103362.","journal-title":"Redox Biol"},{"issue":"1","key":"7226_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12943-020-01237-y","volume":"19","author":"C Zhou","year":"2020","unstructured":"Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X, et al. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt\/\u03b2-catenin and autophagy pathway through modulating the miR-619-5p\/Pygo2 and miR-619-5p\/ATG14 axes. Mol Cancer. 2020;19(1):118.","journal-title":"Mol Cancer"},{"issue":"1","key":"7226_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12943-017-0583-1","volume":"16","author":"P Han","year":"2017","unstructured":"Han P, Li JW, Zhang BM, Lv JC, Li YM, Gu XY, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt\/\u03b2-catenin signaling. Mol Cancer. 2017;16(1):9.","journal-title":"Mol Cancer"},{"issue":"1","key":"7226_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41420-022-00886-w","volume":"8","author":"J Wang","year":"2022","unstructured":"Wang J, Dong Z, Sheng Z, Cai Y. Hypoxia-induced PVT1 promotes lung cancer chemoresistance to cisplatin by autophagy via PVT1\/miR-140-3p\/ATG5 axis. Cell Death Discov. 2022;8(1):104.","journal-title":"Cell Death Discov"},{"issue":"1","key":"7226_CR18","doi-asserted-by":"publisher","first-page":"2038852","DOI":"10.1080\/19490976.2022.2038852","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang L, Zheng S, Li M, Xu C, Jia D, et al. Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1\/NF-\u03baB\/ICAM1 axis. Gut Microbes. 2022;14(1):2038852.","journal-title":"Gut Microbes"},{"issue":"3","key":"7226_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/19490976.2019.1695494","volume":"11","author":"S Chen","year":"2020","unstructured":"Chen S, Su T, Zhang Y, Lee A, He J, Ge Q, et al. Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS\/KRT7. Gut Microbes. 2020;11(3):511\u201325.","journal-title":"Gut Microbes"},{"issue":"1","key":"7226_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"9","key":"7226_CR21","doi-asserted-by":"publisher","first-page":"6481","DOI":"10.1002\/jcp.30323","volume":"236","author":"KC Huang","year":"2021","unstructured":"Huang KC, Chiang SF, Yang PC, Ke TW, Chen TW, Lin CY, et al. ATAD3A stabilizes GRP78 to suppress er stress for acquired chemoresistance in colorectal cancer. J Cell Physiol. 2021;236(9):6481\u201395.","journal-title":"J Cell Physiol"},{"issue":"5","key":"7226_CR22","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1158\/0008-5472.CAN-13-1865","volume":"74","author":"T Tahara","year":"2014","unstructured":"Tahara T, Yamamoto E, Suzuki H, Maruyama R, Chung W, Garriga J, et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 2014;74(5):1311\u201318.","journal-title":"Cancer Res"},{"issue":"17","key":"7226_CR23","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/s41388-023-02657-y","volume":"42","author":"X Zhang","year":"2023","unstructured":"Zhang X, Ma D, Xuan B, Shi D, He J, Yu M, et al. LncRNA CACClnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51. Oncogene. 2023;42(17):1374\u201391.","journal-title":"Oncogene"},{"key":"7226_CR24","doi-asserted-by":"publisher","first-page":"110412","DOI":"10.1016\/j.cbi.2023.110412","volume":"374","author":"F Liu","year":"2023","unstructured":"Liu F, Wang Y, Cao Y, Wu Z, Ma D, Cai J, et al. Transcription factor B-MYB activates lncRNA CCAT1 and upregulates SOCS3 to promote chemoresistance in colorectal cancer. Chem Biol Interact. 2023;374:110412.","journal-title":"Chem Biol Interact"},{"issue":"10","key":"7226_CR25","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41419-021-04118-4","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ren D, Zhou Y, Shen J, Wu H, Jin X. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1\/EZH2 complex in pancreatic cancer. Cell Death Dis. 2021;12(10):878.","journal-title":"Cell Death Dis"},{"issue":"4","key":"7226_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","volume":"152","author":"Y Yang","year":"2017","unstructured":"Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y, et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-\u03baB, and up-regulating expression of MicroRNA-21. Gastroenterology. 2017;152(4):851\u201366.e24.","journal-title":"Gastroenterology"},{"issue":"1","key":"7226_CR27","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"7226_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41522-023-00472-7","volume":"10","author":"Q Tang","year":"2024","unstructured":"Tang Q, Huang H, Xu H, Xia H, Zhang C, Ye D, et al. Endogenous coriobacteriaceae enriched by a high-fat diet promotes colorectal tumorigenesis through the CPT1A-ERK axis. NPJ Biofilms Microbiomes. 2024;10(1):5.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"10","key":"7226_CR29","doi-asserted-by":"publisher","first-page":"11073","DOI":"10.1002\/cam4.5594","volume":"12","author":"SC Ma","year":"2023","unstructured":"Ma SC, Zhang JQ, Yan TH, Miao MX, Cao YM, Cao YB, et al. Novel strategies to reverse chemoresistance in colorectal cancer. Cancer Med. 2023;12(10):11073\u201396.","journal-title":"Cancer Med"},{"issue":"6161","key":"7226_CR30","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342(6161):967\u201370.","journal-title":"Science"},{"issue":"6","key":"7226_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41575-024-00930-3","volume":"21","author":"K Ray","year":"2024","unstructured":"Ray K. A crucial fusobacterium nucleatum clade in colorectal cancer. Nat Rev Gastroenterol Hepatol. 2024;21(6):375.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7226_CR32","doi-asserted-by":"crossref","unstructured":"Yang Y, Jobin C. Far reach of Fusobacterium nucleatum in cancer metastasis. Gut. 2020.","DOI":"10.1136\/gutjnl-2020-323496"},{"issue":"1","key":"7226_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13046-018-0845-9","volume":"37","author":"M Kang","year":"2018","unstructured":"Kang M, Ren M, Li Y, Fu Y, Deng M, Li C. Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous rna. J Exp Clin Cancer Res. 2018;37(1):171.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"7226_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41419-019-1585-2","volume":"10","author":"L Zhu","year":"2019","unstructured":"Zhu L, Zhu Y, Han S, Chen M, Song P, Dai D, et al. Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer. Cell Death Dis. 2019;10(6):383.","journal-title":"Cell Death Dis"},{"issue":"12","key":"7226_CR35","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1080\/15548627.2021.1901204","volume":"17","author":"Y Luo","year":"2021","unstructured":"Luo Y, Zheng S, Wu Q, Wu J, Zhou R, Wang C, et al. Long noncoding rna (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation. Autophagy. 2021;17(12):4083\u2013101.","journal-title":"Autophagy"},{"issue":"3","key":"7226_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.bbrc.2015.04.121","volume":"462","author":"XW Zhang","year":"2015","unstructured":"Zhang XW, Bu P, Liu L, Zhang XZ, Li J. Overexpression of long non-coding rna PVT1 in gastric cancer cells promotes the development of multidrug resistance. Biochem Biophys Res Commun. 2015;462(3):227\u201332.","journal-title":"Biochem Biophys Res Commun"},{"issue":"37","key":"7226_CR37","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1038\/s41388-021-01971-7","volume":"40","author":"MX Zhang","year":"2021","unstructured":"Zhang MX, Zhang LZ, Fu LM, Yao HH, Tan L, Feng ZH, et al. Positive feedback regulation of lncRNA PVT1 and HIF2\u03b1 contributes to clear cell renal cell carcinoma tumorigenesis and metastasis. Oncogene. 2021;40(37):5639\u201350.","journal-title":"Oncogene"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07226-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07226-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07226-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:12:20Z","timestamp":1760602340000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07226-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7226"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07226-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Methods The methods were performed in accordance with the approved guidelines, and all experimental protocols were approved by the Ethics Committee of the Fourth Affiliated Hospital of Hebei Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential competing interests was associated with this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1112"}}